The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1148
ISSUE 1148
January 20, 2003
Issue 1148
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Augmentin XR
January 20, 2003 (Issue: 1148)
Augmentin XR (GlaxoSmithKline), an oral extended-release combination of amoxicillin and the beta-lactamase inhibitor clavulanic acid, is now being promoted for treatment of acute bacterial sinusitis and community-acquired pneumonia. Augmentin XR...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.